However, the expression of EphB2 is low in other tumors, such as colorectal cancer and bladder cancer (Xi et al., 2012; Lee et al., 2021), indicating that it exerts a tumor-suppression effect. This evidence concerns the gene EPHB2 and colorectal cancer.